Rapid SARS-CoV-2 IgG Antibody Testing in high risk healthcare workers and candidacy for convalescent plasma therapy/prophylaxis

C
Courtney Rowan, MD

Primary Investigator

Overview

The purpose of the research is to determine if a certain marker in the blood (IgG to SARS-CoV-2) can tell if persons have been exposed to and now recovered from SARS-CoV-2.

Description

Participants will be given a kit and a link to fill out a short questionnaire to determine demographics, potential exposure risk, and the presence of recent clinical symptoms consistent with SARS-COV-2 infection. Contact information will also be collected.

A kit and instructions will be given to participants to perform a single blood test at home. Blood will be obtained via a finger prick. Procedure takes 2-3 minutes with results available within 10 minutes. If the test is negative: no further intervention, continue prevention as usual, can be retested with finger prick test in 21 days for a maximum of three times. If the test is positive: blood draw for serologic testing of IgG and validate the rapid test, and a nasal swab at an IU Health testing site to confirm by PCR (polymerase chain reaction) that the infection is not active anymore.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    COVID-19, COVID, SARS-CoV-2, Coronavirus
  • Age: Between 18 Years - 100 Years
  • Gender: All

High risk healthcare workers working in the emergency room or intensive care units at IU Health or IU school of Medicine affiliated facilities.

Individuals who have been previously tested for COVID-19 will not be eligible.

Updated on 20 Nov 2022. Study ID: 2003973826

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center